TBPH
Theravance Biopharma, Inc.
Theravance Biopharma, Inc. (TBPH) has 14 SEC Form 4 filings (19 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Jul 8, 2026.
The most active filer is 10% Owner Samaha Eli with 5 filings. Insiders have net sold $6.1M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Rick E. Winningham
- Employees:97
- HQ:George Town, US
- IPO:2014-05-16
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$6.1M
reported sales (SEC code S)
Unique Insiders
2
in the rolling window
Market Cap
$876.4M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| 10% Owner | Sale | 1,400 | $24K | Jul 8 | SEC ↗ | |
| 10% Owner | Sale | 5,564 | $96K | Jul 8 | SEC ↗ | |
Samaha EliFirst filing | 10% Owner | Sale | 273,871 | $4.7M | Jul 1 | SEC ↗ |
Samaha EliFirst filing | 10% Owner | Sale | 25,027 | $429K | Jul 1 | SEC ↗ |
Samaha EliFirst filing | 10% Owner | Sale | 37,799 | $643K | Jul 1 | SEC ↗ |
Farnum RhondaFirst filing | SVP, COMM & MEDICAL AFFAIRS | Sale | 13,314 | $218K | Jun 17 | SEC ↗ |
Related companies
Theravance Biopharma, Inc. is in the Healthcare sector.